View in EDS HTML Full Text PDF Full Text

Preclinical NCI-MPACT: prospective modeling of the mutation-based NCI-MPACT clinical trial therapeutic strategy in patient-derived xenograft models.

Saved in:
Bibliographic Details
Title: Preclinical NCI-MPACT: prospective modeling of the mutation-based NCI-MPACT clinical trial therapeutic strategy in patient-derived xenograft models.
Authors: Evrard YA; Applied and Developmental Research Directorate (ADRD), Frederick National Laboratory for Cancer Research, Frederick, MD, United States., Alcoser SY; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States., Mullendore M; Applied and Developmental Research Directorate (ADRD), Frederick National Laboratory for Cancer Research, Frederick, MD, United States., Chen L; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, United States., Lih CJ; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, United States., Kannan VR; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, United States., Datta V; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, United States., Dutko L; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, United States., Jiwani S; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, United States., Rubinstein LV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States., Zhao Y; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States., Williams PM; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, United States., Palmisano A; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States.; General Dynamics Information Technology (GDIT), Falls Church, VA, United States., Kuhlmann L; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States., Simpson M; Applied and Developmental Research Directorate (ADRD), Frederick National Laboratory for Cancer Research, Frederick, MD, United States., Kummar S; Division of Hematology/Medical Oncology, School of Medicine, Oregon Health & Science University, Portland, OR, United States., Das B; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, United States., Karlovich C; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, United States., Polley E; Department of Public Health Sciences, University of Chicago, Chicago, IL, United States., Li MC; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States., Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States., Hollingshead MG; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States., Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States.; Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.
Source: Frontiers in oncology [Front Oncol] 2025 May 19; Vol. 15, pp. 1571635. Date of Electronic Publication: 2025 May 19 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40458731
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Preclinical NCI-MPACT: prospective modeling of the mutation-based NCI-MPACT clinical trial therapeutic strategy in patient-derived xenograft models.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Evrard+YA%22">Evrard YA</searchLink>; Applied and Developmental Research Directorate (ADRD), Frederick National Laboratory for Cancer Research, Frederick, MD, United States.<br /><searchLink fieldCode="AU" term="%22Alcoser+SY%22">Alcoser SY</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Mullendore+M%22">Mullendore M</searchLink>; Applied and Developmental Research Directorate (ADRD), Frederick National Laboratory for Cancer Research, Frederick, MD, United States.<br /><searchLink fieldCode="AU" term="%22Chen+L%22">Chen L</searchLink>; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, United States.<br /><searchLink fieldCode="AU" term="%22Lih+CJ%22">Lih CJ</searchLink>; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, United States.<br /><searchLink fieldCode="AU" term="%22Kannan+VR%22">Kannan VR</searchLink>; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, United States.<br /><searchLink fieldCode="AU" term="%22Datta+V%22">Datta V</searchLink>; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, United States.<br /><searchLink fieldCode="AU" term="%22Dutko+L%22">Dutko L</searchLink>; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, United States.<br /><searchLink fieldCode="AU" term="%22Jiwani+S%22">Jiwani S</searchLink>; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, United States.<br /><searchLink fieldCode="AU" term="%22Rubinstein+LV%22">Rubinstein LV</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Zhao+Y%22">Zhao Y</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Williams+PM%22">Williams PM</searchLink>; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, United States.<br /><searchLink fieldCode="AU" term="%22Palmisano+A%22">Palmisano A</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States.; General Dynamics Information Technology (GDIT), Falls Church, VA, United States.<br /><searchLink fieldCode="AU" term="%22Kuhlmann+L%22">Kuhlmann L</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Simpson+M%22">Simpson M</searchLink>; Applied and Developmental Research Directorate (ADRD), Frederick National Laboratory for Cancer Research, Frederick, MD, United States.<br /><searchLink fieldCode="AU" term="%22Kummar+S%22">Kummar S</searchLink>; Division of Hematology/Medical Oncology, School of Medicine, Oregon Health & Science University, Portland, OR, United States.<br /><searchLink fieldCode="AU" term="%22Das+B%22">Das B</searchLink>; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, United States.<br /><searchLink fieldCode="AU" term="%22Karlovich+C%22">Karlovich C</searchLink>; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD, United States.<br /><searchLink fieldCode="AU" term="%22Polley+E%22">Polley E</searchLink>; Department of Public Health Sciences, University of Chicago, Chicago, IL, United States.<br /><searchLink fieldCode="AU" term="%22Li+MC%22">Li MC</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Chen+AP%22">Chen AP</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Hollingshead+MG%22">Hollingshead MG</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Doroshow+JH%22">Doroshow JH</searchLink>; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States.; Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2025 May 19; Vol. 15, pp. 1571635. <i>Date of Electronic Publication: </i>2025 May 19 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40458731
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2025.1571635
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1571635
    Titles:
      – TitleFull: Preclinical NCI-MPACT: prospective modeling of the mutation-based NCI-MPACT clinical trial therapeutic strategy in patient-derived xenograft models.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Evrard YA
      – PersonEntity:
          Name:
            NameFull: Alcoser SY
      – PersonEntity:
          Name:
            NameFull: Mullendore M
      – PersonEntity:
          Name:
            NameFull: Chen L
      – PersonEntity:
          Name:
            NameFull: Lih CJ
      – PersonEntity:
          Name:
            NameFull: Kannan VR
      – PersonEntity:
          Name:
            NameFull: Datta V
      – PersonEntity:
          Name:
            NameFull: Dutko L
      – PersonEntity:
          Name:
            NameFull: Jiwani S
      – PersonEntity:
          Name:
            NameFull: Rubinstein LV
      – PersonEntity:
          Name:
            NameFull: Zhao Y
      – PersonEntity:
          Name:
            NameFull: Williams PM
      – PersonEntity:
          Name:
            NameFull: Palmisano A
      – PersonEntity:
          Name:
            NameFull: Kuhlmann L
      – PersonEntity:
          Name:
            NameFull: Simpson M
      – PersonEntity:
          Name:
            NameFull: Kummar S
      – PersonEntity:
          Name:
            NameFull: Das B
      – PersonEntity:
          Name:
            NameFull: Karlovich C
      – PersonEntity:
          Name:
            NameFull: Polley E
      – PersonEntity:
          Name:
            NameFull: Li MC
      – PersonEntity:
          Name:
            NameFull: Chen AP
      – PersonEntity:
          Name:
            NameFull: Hollingshead MG
      – PersonEntity:
          Name:
            NameFull: Doroshow JH
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 05
              Text: 2025 May 19
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1